Marc Henzler

Ten years ago, Ambu launched the world’s first single-use flexible endoscope: The Ambu® aScope™. The aScope is now used at more than 3,000 hospitals across the globe proving its worth in both pulmonary and ENT endoscopy. By 2020, Ambu will bring the advantages of sterile-single-use endoscopes to all areas of gastroenterology in the form of: duodenoscopes, colonoscopes and gastroscopes.

Revolutionary Square Endoscopy Our technology enables, for the first time, to dramatically reduce the optical component’s diameter without compromising and even improving image quality to achieve never before seen visualizations. Zsquare aims to advance endoscopic diagnostic technologies, with the purpose of democratizing patient care and optimizing patient outcomes and hospital efficiency.

NLC is the European healthtech venture builder, bringing science-based healthtech inventions to life.

HaimaChek Inc. is a Medical Device Company developing and producing an innovative and disruptive technology for in vivo blood biopsy aimed at isolation of rare cells, pathogens and nucleic acids. HaimaChek's flagship product is a percutaneous BMProbe for the collection, isolation and identification of rare circulating tumor cells (CTCs) and circulating endothelial cells (CECs).

The Digital Endoscopy GmbH is a subsidiary of HOYA Corporation and supports the PENTAX Medical group in research and development. Based in Friedberg, Bavaria, center of Germany's medical technology frontier, Digital Endoscopy develops innovative endoscopic imaging products.

founder and managing director of the company, acquired by Hoya Corporation, Tokyo, Japan in 2012

Digital Strategies for Business: Leading the next-generation enterprise, focuses on how managers can innovate new strategies and business models to enable their organisation to thrive in the digital age.

Hamburger Fernhochschule